Assertio Holdings, Inc.
ASRT
Price:
$0.785
Market Cap:
$75.56M
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for the treatment of migraine, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate acute pain; SPRIX, a NSAID for the short term management of moderate to moderately seve...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1997-12-03
Stock Exchange
NASDAQ
Ticker
ASRT
PE Ratio
[-2.62]
ROE
[-37.76%]
Current Ratio
[1.59]
Dividend Yield
[0%]
Enterprise Value
[74.26M]
Dividend History
The ROE as of December 2025 (TTM) for Assertio Holdings, Inc. (ASRT) is -37.76%
According to Assertio Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -37.76%. This represents a change of 273.44% compared to the average of -10.11% of the last 4 quarters.
Assertio Holdings, Inc. (ASRT) Historical ROE (quarterly & annually)
How has ASRT ROE performed in the past?
The mean historical ROE of Assertio Holdings, Inc. over the last ten years is -73.96%. The current -37.76% ROE has changed -48.95% with respect to the historical average. Over the past ten years (40 quarters), ASRT's ROE was at its highest in in the March 2020 quarter at 49.06%. The ROE was at its lowest in in the December 2019 quarter at -332.35%.
Average
-73.96%
Median
-29.71%
Minimum
-374.76%
Maximum
48.57%
Assertio Holdings, Inc. (ASRT) ROE by Quarter and Year
Discovering the peaks and valleys of Assertio Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.92%
Maximum Annual ROE = 48.57%
Minimum Annual Increase = -3982.76%
Minimum Annual ROE = -374.76%
| Year | ROE | Change |
|---|---|---|
| 2024 | -17.82% | -92.59% |
| 2023 | -240.53% | -595.27% |
| 2022 | 48.57% | -3982.76% |
| 2021 | -1.25% | -97.53% |
| 2020 | -50.70% | -86.47% |
| 2019 | -374.76% | -2337.23% |
| 2018 | 16.75% | -127.70% |
| 2017 | -60.47% | 70.92% |
| 2016 | -35.38% | 47.16% |
| 2015 | -24.04% | -166.49% |
Assertio Holdings, Inc. (ASRT) Average ROE
How has ASRT ROE performed in the past?
The current ROE of Assertio Holdings, Inc. (ASRT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-69.93%
5-year avg
-52.35%
10-year avg
-73.96%
Assertio Holdings, Inc. (ASRT) ROE vs. Peers
How is ASRT’s ROE compared to its peers?
Assertio Holdings, Inc.’s ROE is greater than InterCure Ltd. (-16.39%), greater than Nutriband Inc. (-131.40%), greater than XBiotech Inc. (-16.73%), less than Fortress Biotech, Inc. (19.24%), greater than Acrivon Therapeutics, Inc. Common Stock (-53.71%), greater than TScan Therapeutics, Inc. (-63.84%), greater than Pulmonx Corporation (-69.76%), greater than Vaxart, Inc. (-123.53%), greater than PMV Pharmaceuticals, Inc. (-47.95%), greater than Lite Strategy, Inc. (-27.11%),
| Company | ROE | Market cap |
|---|---|---|
| -16.39% | $73.55M | |
| -131.40% | $55.23M | |
| -16.73% | $75.91M | |
| 19.24% | $88.45M | |
| -53.71% | $73.84M | |
| -63.84% | $60.16M | |
| -69.76% | $84.76M | |
| -123.53% | $88.58M | |
| -47.95% | $65.98M | |
| -27.11% | $63.09M |
Build a custom stock screener for Assertio Holdings, Inc. (ASRT) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assertio Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Assertio Holdings, Inc. (ASRT) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Assertio Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Assertio Holdings, Inc.'s ROE?
How is the ROE calculated for Assertio Holdings, Inc. (ASRT)?
What is the highest ROE for Assertio Holdings, Inc. (ASRT)?
What is the 3-year average ROE for Assertio Holdings, Inc. (ASRT)?
What is the 5-year average ROE for Assertio Holdings, Inc. (ASRT)?
How does the current ROE for Assertio Holdings, Inc. (ASRT) compare to its historical average?